Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus fermentum CECT5716

Safety profile

3 studies reporting safety data

Across 3 clinical studies, no specific adverse events were quantitatively reported as increased or significantly different for Lactobacillus fermentum CECT5716. The probiotic was described as well tolerated in all studies, with one study reporting diarrhea rates of 7.84% versus 8.0% in the control group, indicating no relevant difference. No serious adverse events were reported. The evidence base is limited to 3 studies, and findings are based on unquantified tolerability statements rather than formal safety analyses.

Caveats: Limited evidence base (3 studies); absence of reported adverse events does not establish safety. Studies were likely not powered to detect rare adverse events. Long-term safety (>8 weeks) and safety in specific populations beyond healthy adults and infants are not characterized.

Most-studied combinations with Lactobacillus fermentum CECT5716

most supplement research is combination research
Also studied with:Lactobacillus reuteri NCIMB 30242 (2)

  • Mum

    By BioGaia

    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $28.99
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top